Arthritis News: Breaking Arthritis News, Comments and Articles. - Page: 5

Vitamin C supplements 'do not lower uric acid levels in people with gout'

Vitamin C supplementation does not have a clinically significant effect on uric acid (urate) levels in people with gout, a study has found.Researchers at the University of Otago in New Zealand assessed 40 patients, all of whom had levels of urate - which crystallises within the joints of people with gout - that exceeded the treatment target level of 0.36 mmol per litre (6mg per 100ml) of blood.Twe...

MRI could provide early warning of failing hip implants

Magnetic resonance imaging (MRI) could be used to identify hip implants that are failing long before patients begin to notice symptoms, a study has found.Researchers at the Hospital for Special Surgery in New York discovered that the scans show up inflammation of the joint lining, known as 'synovitis', in patients whose implants are beginning to fail but who are not yet experiencing any pa...

Vitamin C does not lower uric acid levels in gout patients

(Wiley) Despite previous studies touting its benefit in moderating gout risk, new research reveals that vitamin C, also known ascorbic acid, does not reduce uric acid (urate) levels to a clinically significant degree in patients with established gout...

Diclofenac — a useful drug that may now be entering its twilight years

Diclofenac has been prescribed widely but recently there has been emerging evidence of its cardiovascular side effects. Jenny Bryan investigates Well into its fourth decade on pharmacy shelves, the non-steroidal anti-inflammatory drug diclofenac...

Ultrasound findings can improve classification of RA

(HealthDay)—Compared to clinical diagnosis of synovitis, ultrasound-detected synovitis provides either improved sensitivity or specificity when used with the American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) criteria f...

ABLE questions Indian approval of Cipla biosimilar

India's Association of Biotechnology Led Enterprises sent a letter to the Drug Controller General of India (DCGI) asking whether the approval of biosimilar Etacept from Cipla Ltd. (Mumbai, India) was based on India's Guidelines on Similar Biologics....

SIMPONI® (golimumab) Receives FDA Approval for Ulcerative Colitis

HORSHAM, Pa., May 15, 2013 /PRNewswire/ -- Janssen Biotech, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved SIMPONI® (golimumab) for the treatment of moderately to severely active ulcerative colitis (UC) in adult patients who have demonstrated corticosteroid dependence or who have had an inadequate response to or failed to tolerate oral aminosalicylates...

BioConference Live Hosts High Level Speakers from UCSF at Their Virtual Conference in May

The 4th Annual BioConference Live Clinical Diagnostics Virtual Conference presents cutting-edge research in clinical diagnostics May 29-31, 2013. Yorba Linda, CA (PRWEB) May 15, 2013 BioConference Live is a premiere producer of online conferences aimed at covering a variety of science verticals, including Clinical Diagnostics, Genetics & Genomics, Cancer Research & Discovery, and Laborato...

Additional Genes Linked to Juvenile Arthritis

The number of confirmed genes linked to juvenile idiopathic arthritis has increased from the original three to 17 or possible...

Rituximab: A Popular But Problematic Biosimilar

Roche/ Biogen Idec’s $7 billion oncology and rheumatoid arthritis monoclonal antibody rituximab has been a far more popular target than infliximab for biosimilar developers.

hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces New hCG Diet Plans Designed to Offer Fast Weight Loss, and in Turn Relief for Lower Back Pain

Diet Doc provides medically supervised prescription hCG diet plans that empower patients to successfully achieve fast weight loss, reducing the liability on the lower back and resulting in diminished pain. Memphis, TN (PRWEB) May 15, 2013 Chances of suffering back pain is almost unavoidable for those that are overweight or obese with SpineUniverse reporting that carrying extra pounds significantl...

New survey reveals healthcare professionals’ views about getting involved in research in the NHS

Healthcare professionals universally agree that the NHS should support research into treatments for patients, according to a new survey released today. However, 91% of those surveyed had experienced barriers in taking part in research. Lack of time (62%), funding (30%), practical support (27%) and difficulties navigating regulation (24%) were among the reasons given. The survey of 392 GPs, hos...

ABLYNX ANNOUNCES Q1 2013 BUSINESS UPDATE

REGULATED INFORMATION GHENT, Belgium, 15 May 2013 - Ablynx [Euronext Brussels: ABLX], the Belgian-based biopharmaceutical company focused on the discovery and development of Nanobodies® for the treatment of serious diseases, today announced its business update for the three-month period ending 31st March 2013. Operating highlights Continued progress with the five Nanobody-based products in...

5 Tips for Living with Arthritis, from The CareGiver Partnership

May is Arthritis Month as recognized by the Arthritis Foundation. Dianna Malkowski of The CareGiver Partnership offers five tips for living more comfortably with arthritis. Neenah, Wis. (PRWEB) May 15, 2013 Arthritis, a complex family of musculoskeletal disorders, affects approximately 50 million Americans, according to the Arthritis Foundation, which has recently announced a new multiyear awaren...

Newly Published Medical Research Confirms the Efficacy of Perispinally Administered Etanercept as a Traumatic Brain Injury Treatment

Observational Study by Neurological Wellness Center Physicians Confirms Significant Recoveries with Perispinal Etanercept Administered Years After the Injury. (PRWEB) May 15, 2013 Neurological Recovery Guide and Neurological Wellness Center have been facilitating recovery from TBI since 2010.This research published in the Journal BMC Neuroscience and available online finds; "The TBI induced...

Sanofi recruits patients for arthritis trials

PARIS (Reuters) - French drugmaker Sanofi SA said it and U.S. firm Regeneron Pharmaceuticals have started recruiting patients for two new trials of their arthritis treatment sarilumab.

hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces New hCG Diet Plans Designed to Offer Fast Weight Loss, and in Turn Relief for Lower Back Pain

Memphis, TN (PRWEB) May 15, 2013 Chances of suffering back pain is almost unavoidable for those that are overweight or obese with SpineUniverse reporting that carrying extra pounds significantly increases the risk for diseases of the spine, incl...

Doctors' understanding of rheumatoid disease does not align with patients' experiences

When I was diagnosed as having rheumatoid arthritis in 2006, I knew nothing of its symptoms or treatments. I had no concept of typical disease presentation or what the medical profession thought...

Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)

PARIS and TARRYTOWN, N.Y., May 15, 2013 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the COMPARE and ASCERTAIN trials of sarilumab, the first fully human monoclonal antibody directed against the IL-6 receptor, which is delivered by subcutaneous injection every other week, have enrolled their first patients. The...

Dallas Orthopedic Surgeon Presents a Step-by-Step Guide for Ankle Care

DALLAS, TX -- (Marketwired) -- 05/15/13 -- Dallas orthopedic surgeon, Dr. Brian E. Straus, specializes in the repair of joints that are affected by worn cartilage, trauma, or disease. Ankle injuries make up a large portion of Dr. Straus's patients at All-Star Orthopaedics, and these injuries are common in patients of all ages. Many of Dr. Straus's patients who visit his office for ankle care in...

Do TNF Inhibitors Reduce the Risk of Myocardial Infarction in Psoriasis Patients? TNF Inhibitors and MI Risk in Psoriasis Patients

Jashin J. Wu, MD; Kwun-Yee T. Poon, MS; Jennifer C. Channual, MD; Albert Yuh-Jer Shen, MS, MDObjective: To assess whether patients with psoriasis treated with tumor necrosis factor (TNF) inhibitors have a decreased risk of myocardial infarction (MI)...

Combination of osteoporosis drugs 'better than either on its own'

A combination of the drugs teriparatide and denosumab appears to be better at increasing bone mineral density in postmenopausal women with the bone-thinning disease osteoporosis than either drug on its own or any other available treatment for the disease, a US study has found.Teriparatide is a bone-building or 'anabolic' drug, which works by increasing the activity of osteoblast cells to s...

Celgene: Apremilast For Psoriatic Arthritis Offers Upside

Celgene (CELG) reported data from its ongoing Phase III trial of apremilast this month showing the drug successfully reduced psoriatic arthritis symptoms by at least 20% versus placebo.The data is good news for the 1 million diagnosed patients in the U.S. and Europe and for shareholders eager to see apremilast win market share in the multibillion dollar immunology market. Currently, there is no...

Personalized Medicine for Osteoarthritis

This review reports on the important developments in personalized medicine for the diagnosis and management of osteoarthritis. Therapeutic Advances in Musculoskeletal Disease

Driving Earlier Diagnosis: A Case Study in Psoriatic Arthritis

Précis:  Following a survey of 8000 Psoriatic Arthritis patients, Mary Assimakopoulos shares some of the root causes behind a late diagnosis of this debilitating illness, and the patients’ own feel...